Ocular permeability of pirenzepine hydrochloride enhanced by methoxy poly(ethylene glycol)-poly(D,L-lactide) block copolymer

Drug Development and Industrial Pharmacy

Volumn 33, Issue 10, 2007, Pages 1142-1150

  Tu, Jiasheng ^a   Pang, Hui ^a   Yan, Zhen ^a   Li, Pengmei ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Methoxy poly(ethylene glycol) poly(D,L lactide) block copolymer; Ocular pharmacokinetics; Pirenzepine hydrochloride; Transcorneal permeation

Indexed keywords

COPOLYMER; METHOXY POLY(ETHYLENE GLYCOL) POLY(DEXTRO,LEVO LACTIDE); PIRENZEPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSIS; DRUG INSTILLATION; DRUG PENETRATION; DRUG SYNTHESIS; EYE TOXICITY; FEMALE; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; POLYMERIZATION; RABBIT; RING OPENING;

ANIMALS; CORNEA; DRUG CARRIERS; FEMALE; MALE; MICELLES; PARTICLE SIZE; PERMEABILITY; PIRENZEPINE; POLYESTERS; POLYETHYLENE GLYCOLS; RABBITS;

EID: 35648948980     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701397381     Document Type: Article

References (9)

1. Dai, Y., & Chu, R. (2002). The pharmacokinetic of pirenzipine in the aqueous humor of rabbits. Chin. J. of Optometry & Ophthalmol., 4(4), 228-229.
2. Gupta, A., & Madan, S. (2000). Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int. J. Pharm., 209, 1-14.
3. Hubbell, J. (2003). Enhancing drug function. Science, 300(25), 595-596.
4. Savic, R., & Luo, L. (2003). Micellar nanocontainers distribute to defined cytoplasmic organelles. Science, 300(25), 615-618.
5. Soga, O., & Nostrum, C. F. (2004). Physicochemical characterization of degradable thermosensitive polymeric micelles. Langmuir, 20(21), 9388-9395.
6. Tan, D., Lam, D. S., et al. (2005). One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology, 112(1), 84-91.
7. Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J. Contr. Release, 73, 137-172.
8. Truong, H. T., Cottriall, C. L. et al. (2002). Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. Exp. Eye Res., 74(1), 103-111.
9. Tu, J., & Li, P. (2005) HPLC determination of pirenzepine dihydrochloride in rabbit aqueous humor. J. Chromatogr. B., 822, 300-303.